AMRN - Amarin GAAP EPS of -$0.03 beats by $0.22, revenue of $72.74M beats by $18.98M
2025-07-30 07:02:54 ET
More on Amarin
- Amarin Is A Sell Despite The Large Cash Balance
- Amarin Corporation plc (AMRN) Q1 2025 Earnings Call Transcript
- Amarin Corporation plc 2025 Q1 - Results - Earnings Call Presentation
- Amarin Q2 2025 Earnings Preview
- Amarin inks licensing deal with Recordati for lead drug Vazkepa